Clinical Cancer Drugs - Current Issue

CAR-T cell therapy has transformed cancer treatment by harnessing genetically engineered T cells to specifically target and destroy cancer cells, especially in blood cancers like leukemia and lymphoma. Despite its success, challenges such as serious side effect cytokine release syndrome, neurotoxicity and the high cost of treatment hinder widespread access. Research is ongoing to broaden its use to solid tumors and impr Read More

Utilizing the body's immune system to combat cancer has become a viable tactic known as cancer immunotherapy. Metallic nanoparticles, or MNPs, have drawn a lot of interest because of their special qualities and their uses in cancer immunotherapy. The manufacturing processes of MNPs, their function in altering the tumor microenvironment (TME), and their capacity to control immune cells for potent anticancer effects are all t Read More

In the realm of nanomedicine, graphene quantum dots (GQDs) stand at the forefront, offering transformative potential for cancer diagnosis and therapy. Possessing exceptional optical and electronic properties, biocompatibility, and versatile surface customization, GQDs emerge as powerful tools for advanced imaging and targeted drug delivery. Synthesized through innovative bottom-up and top-down methods, GQDs presen Read More

Despite the major advancements in cancer treatment, colon cancer (CC) is still one of the most lethal malignancies worldwide. Among various type of cancer, it is the third largest prevailing kind of cancer affecting both men and women equally. Metastatic development is particularly common in individuals with advanced stages and frequently associated with subpar response of chemotherapy and severe morbidity. The unfavorab Read More